FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 18th, 2024 • 374Water Inc. • Motors & generators • New York
Contract Type FiledNovember 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 14, 2024 between 374Water Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 18th, 2024 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 15, 2024, between Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 15th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 15th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 12, 2024, between Virpax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 14th, 2024 • Glucotrack, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 14th, 2024 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of November 13, 2024, between Glucotrack, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 14th, 2024 • Humacyte, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 14th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 13, 2024, between Humacyte, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 8th, 2024 • Glucotrack, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 8th, 2024 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of November [__], 2024, between Glucotrack, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 6th, 2024 • Stryve Foods, Inc. • Food and kindred products • New York
Contract Type FiledNovember 6th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November ____, 2024, between Stryve Foods, Inc., a company incorporated under the laws of Delaware (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 4th, 2024 • Glucotrack, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 4th, 2024 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of November [__], 2024, between Glucotrack, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 1st, 2024 • Shuttle Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 1st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 29, 2024, between Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 31st, 2024 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 31st, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October [•], 2024, between Aptose Biosciences Inc., a Canadian corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 28th, 2024 • Senseonics Holdings, Inc. • Industrial instruments for measurement, display, and control • New York
Contract Type FiledOctober 28th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 24, 2024, between Senseonics Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 24th, 2024 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of October [ ], 2024, between Qualigen Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 21st, 2024 • bioAffinity Technologies, Inc. • Services-commercial physical & biological research • New York
Contract Type FiledOctober 21st, 2024 Company Industry JurisdictionTHIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of October 18, 2024, by and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 18th, 2024 • Shuttle Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of [●] 2024, between Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 18th, 2024 • iSpecimen Inc. • Services-commercial physical & biological research • New York
Contract Type FiledOctober 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _, 2024, between iSpecimen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 18th, 2024 • Kartoon Studios, Inc. • Services-motion picture & video tape production • New York
Contract Type FiledOctober 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ____, 2024, between Kartoon Studios, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 16th, 2024 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 16th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 15, 2024, between Rani Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 15th, 2024 • Top Wealth Group Holding LTD • Miscellaneous food preparations & kindred products • New York
Contract Type FiledOctober 15th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October __, 2024, between Top Wealth Group Holding Limited, a Cayman Islands exempt company with limited liability (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 11th, 2024 • Netlist Inc • Semiconductors & related devices • New York
Contract Type FiledOctober 11th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 11, 2024, between Netlist, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 7th, 2024 • Humacyte, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledOctober 7th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 4, 2024, between Humacyte, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 7th, 2024 • Digital Brands Group, Inc. • Retail-apparel & accessory stores • New York
Contract Type FiledOctober 7th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of [●], 2024, between Digital Brands Group Inc., a company incorporated under the laws of Delaware (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 3rd, 2024 • Oncocyte Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledOctober 3rd, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 2, 2024, between Oncocyte Corporation, a California corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 30th, 2024 • Theriva Biologics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 30th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September 26, 2024, between Theriva Biologics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2024 • Heart Test Laboratories, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledSeptember 27th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of , 2024, between Heart Test Laboratories, Inc., a Texas corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2024 • Edible Garden AG Inc • Agricultural production-crops • New York
Contract Type FiledSeptember 27th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 27 2024, between Edible Garden AG Incorporated, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 24th, 2024 • Top Wealth Group Holding LTD • Miscellaneous food preparations & kindred products • New York
Contract Type FiledSeptember 24th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of __, 2024, between Top Wealth Group Holding Limited, a Cayman Islands exempt company with limited liability (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 20th, 2024 • Vivos Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledSeptember 20th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2024, between Vivos Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 18th, 2024 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 16, 2024, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2024 • Focus Universal Inc. • Industrial instruments for measurement, display, and control • New York
Contract Type FiledSeptember 17th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 15, 2024, between Focus Universal Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 17th, 2024 • Edible Garden AG Inc • Agricultural production-crops • New York
Contract Type FiledSeptember 17th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September __ 2024, between Edible Garden AG Incorporated, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 10th, 2024 • Theriva Biologics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 10th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of September [•], 2024, between Theriva Biologics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 10th, 2024 • Eastside Distilling, Inc. • Beverages • New York
Contract Type FiledSeptember 10th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 5, 2024, between Eastside Distilling, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 5th, 2024 • Richtech Robotics Inc. • General industrial machinery & equipment, nec • New York
Contract Type FiledSeptember 5th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 29, 2024, between Richtech Robotics Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 4th, 2024 • Airship AI Holdings, Inc. • Services-prepackaged software • New York
Contract Type FiledSeptember 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 29, 2024, between Airship AI Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 30th, 2024 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 30th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of ______, 2024, between Aptevo Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).